drugset / Trial / NCT00869986
A Study for Patients With Relapsing Remitting Multiple Sclerosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test if dirucotide is safe and effective in treating patients with relapsing remitting multiple sclerosis.
Timeline
- Start
- 2006-11
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dirucotide | Protein / enzyme biologic | 500 mg | Intravenous |